Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Compensatie door gezonde hersendelen verlicht klachten bij Parkinson
nov 2023 | Bewegingsstoornissen